Literature DB >> 21484138

Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis.

Shotaro Enomoto1, Hideyuki Tamai, Naoki Shingaki, Yoshiyuki Mori, Kosaku Moribata, Tatsuya Shiraki, Hisanobu Deguchi, Kazuki Ueda, Izumi Inoue, Takao Maekita, Mikitaka Iguchi, Kimihiko Yanaoka, Masashi Oka, Masao Ichinose.   

Abstract

PURPOSE: To establish a method of assessing the malignant potential of hepatocellular carcinoma (HCC) using magnetic resonance imaging (MRI).
METHODS: For 69 nodules [12 Edmondson (Ed)-I, 48 Ed-II, 9 Ed-III] in 54 HCC patients, signal intensity patterns and enhancement patterns of gadopentate dimeglumine (Gd-DTPA) dynamic studies were correlated with histological differentiation and serum lens culinaris agglutinin-reactive alpha-fetoprotein (AFP-L3) level, which is an indicator of poor prognosis.
RESULTS: Hypointensity on T1-weighted imaging was seen in 17, 72, and 89% of Ed-I, Ed-II, and Ed-III HCCs, respectively (P < 0.001). Meanwhile, hyperintensity on T2-weighted imaging was seen in 42, 88, and 89% (P < 0.005). Tumor stain during the arterial phase of Gd dynamic MRI was seen in 75, 86, and 89%. Tumor stain washout during the portal phase was seen in 43% of Ed-II and 100% of Ed-III HCCs (P < 0.005). In the Ed-II and Ed-III HCCs, hypointensity on T1-weighted imaging was seen in 65% of AFP-L3-negative HCCs and 90% of AFP-L3-positive HCCs (P = 0.071). Washout of tumor stain during the portal phase was seen in 39% of AFP-L3-negative HCCs and 75% of AFP-L3-positive HCCs (P < 0.05).
CONCLUSIONS: Although hyperintensity of tumor on T2-weighted imaging and arterial hypervascularity of tumor are considered to be useful for differential diagnosis between well differentiated HCCs and moderately/poorly differentiated HCCs, hypointensity of tumor on T1-weighted imaging and tumor stain washout during the portal phase of Gd-DTPA dynamic MRI reflected poorer histological differentiation of HCCs and correlated with AFP-L3 levels.

Entities:  

Year:  2011        PMID: 21484138      PMCID: PMC3090556          DOI: 10.1007/s12072-010-9245-8

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  31 in total

1.  Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results.

Authors:  Seong Hyun Kim; Hyo K Lim; Dongil Choi; Won Jae Lee; Seung Hoon Kim; Min Ju Kim; Chan Kyo Kim; Yong Hwan Jeon; Jong Mee Lee; Hyunchul Rhim
Journal:  AJR Am J Roentgenol       Date:  2006-05       Impact factor: 3.959

2.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

3.  Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma.

Authors:  Saburo Fukuda; Toshiyuki Itamoto; Hideki Nakahara; Toshihiko Kohashi; Hideki Ohdan; Hiroshi Hino; Makoto Ochi; Hirotaka Tashiro; Toshimasa Asahara
Journal:  Hepatogastroenterology       Date:  2005 Jul-Aug

4.  Well-differentiated hepatocellular carcinoma: clinicopathological features and results of hepatic resection.

Authors:  M Sato; Y Watanabe; T Lee; K Kito; S Kimura; Y Itoh; K Akamatsu; N Ueda
Journal:  Am J Gastroenterol       Date:  1995-01       Impact factor: 10.864

5.  A case of rapid intrahepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation.

Authors:  Nicola Nicoli; Andrea Casaril; Moh'd Abu Hilal; Gerardo Mangiante; Luigi Marchiori; Michele Ciola; Laura Invernizzi; Tommaso Campagnaro; Giancarlo Mansueto
Journal:  Am J Surg       Date:  2004-08       Impact factor: 2.565

6.  Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma.

Authors:  M Ebara; H Fukuda; Y Kojima; N Morimoto; M Yoshikawa; N Sugiura; T Satoh; F Kondo; M Yukawa; T Matsumoto; H Saisho
Journal:  Radiology       Date:  1999-01       Impact factor: 11.105

7.  Early hepatocellular carcinoma: MR imaging.

Authors:  Y Muramatsu; S Nawano; K Takayasu; N Moriyama; T Yamada; S Yamasaki; S Hirohashi
Journal:  Radiology       Date:  1991-10       Impact factor: 11.105

8.  Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation.

Authors:  Andrea Ruzzenente; Giovanni De Manzoni; Matteo Molfetta; Silvia Pachera; Bruno Genco; Matteo Donataccio; Alfredo Guglielmi
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

9.  Aggressive recurrence after radiofrequency ablation of liver neoplasms.

Authors:  Nazario Portolani; Guido Alberto Massimo Tiberio; Maurizio Ronconi; Arianna Coniglio; Sara Ghidoni; Giacomo Gaverini; Stefano Maria Giulini
Journal:  Hepatogastroenterology       Date:  2003 Nov-Dec

10.  Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma.

Authors:  Yasutsugu Takada; Masanao Kurata; Nobuhiro Ohkohchi
Journal:  Int J Clin Oncol       Date:  2003-10       Impact factor: 3.402

View more
  9 in total

Review 1.  Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.

Authors:  Norihide Yoneda; Osamu Matsui; Satoshi Kobayashi; Azusa Kitao; Kazuto Kozaka; Dai Inoue; Kotaro Yoshida; Tetsuya Minami; Wataru Koda; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2019-02-02       Impact factor: 2.374

2.  Hepatocellular carcinoma pathologic grade prediction using radiomics and machine learning models of gadoxetic acid-enhanced MRI: a two-center study.

Authors:  Yeo Eun Han; Yongwon Cho; Min Ju Kim; Beom Jin Park; Deuk Jae Sung; Na Yeon Han; Ki Choon Sim; Yang Shin Park; Bit Na Park
Journal:  Abdom Radiol (NY)       Date:  2022-09-21

Review 3.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-10       Impact factor: 11.105

4.  MRI Features for Predicting Microvascular Invasion of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Seung Baek Hong; Sang Hyun Choi; So Yeon Kim; Ju Hyun Shim; Seung Soo Lee; Jae Ho Byun; Seong Ho Park; Kyung Won Kim; Suk Kim; Nam Kyung Lee
Journal:  Liver Cancer       Date:  2021-03-11       Impact factor: 11.740

5.  Preoperative evaluation of the histological grade of hepatocellular carcinoma with diffusion-weighted imaging: a meta-analysis.

Authors:  Jie Chen; Mingpeng Wu; Rongbo Liu; Siyi Li; Ronghui Gao; Bin Song
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 6.  MRI features of hepatocellular carcinoma related to biologic behavior.

Authors:  Eun-Suk Cho; Jin-Young Choi
Journal:  Korean J Radiol       Date:  2015-05-13       Impact factor: 3.500

7.  Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography.

Authors:  Kenichiro Nakachi; Hideyuki Tamai; Yoshiyuki Mori; Naoki Shingaki; Kosaku Moribata; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Jun Kato; Masao Ichinose
Journal:  Cancer Imaging       Date:  2014-04-22       Impact factor: 3.909

8.  Meta-analysis of the prognostic value of abnormally expressed lncRNAs in hepatocellular carcinoma.

Authors:  Zhen Qu; Chun-Hui Yuan; Chang-Qing Yin; Qing Guan; Hao Chen; Fu-Bing Wang
Journal:  Onco Targets Ther       Date:  2016-08-18       Impact factor: 4.147

9.  Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results.

Authors:  Bachir Taouli; Yujin Hoshida; Suguru Kakite; Xintong Chen; Poh Seng Tan; Xiaochen Sun; Shingo Kihira; Kensuke Kojima; Sara Toffanin; M Isabel Fiel; Hadassa Hirschfield; Mathilde Wagner; Josep M Llovet
Journal:  Eur Radiol       Date:  2017-04-24       Impact factor: 7.034

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.